DCTH
Delcath Systems (DCTH)
$03
About Delcath Systems (DCTH)
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Details
Daily high
$10.20
Daily low
$9.84
Price at open
$10.04
52 Week High
$18.23
52 Week Low
$8.12
Market cap
356.0M
Dividend yield
0.00%
Volume
491,649
Avg. volume
766,173
P/E ratio
1,172.09
Delcath Systems News
Details
Daily high
$10.20
Daily low
$9.84
Price at open
$10.04
52 Week High
$18.23
52 Week Low
$8.12
Market cap
356.0M
Dividend yield
0.00%
Volume
491,649
Avg. volume
766,173
P/E ratio
1,172.09